SEC Tracker
Get the app

GeoVax Labs GOVX

GeoVax Labs approves warrant exercise and reverse stock split

Item 5.07 Shareholder vote results

Form
8-K
Filed
Importance
Routine
  1. 4,326,013 proxies received out of 9,093,871 shares
  2. 11,395,256 shares approved for warrant exercise
  3. Reverse stock split ratio between 1-for-10 and 1-for-25 approved

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when GeoVax Labs files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Earth Science Tech ETST public float $14M, Mar 31, 2026
  2. Edesa Biotech EDSA public float $14M, Mar 31, 2025, over 18 months old
  3. Synergy CHC SNYR public float $13M, Jun 30, 2025
  4. Cellectar Biosciences CLRB public float $13M, Jun 30, 2025
  5. X4 Pharmaceuticals XFOR public float $15M, Jun 30, 2025